The prognostic significance of estrogen receptor β in head and neck squamous cell carcinoma

Grsic,Kresimir; Opacic,Iva  Ledinsky; Sitic,Sanda; Milkovic Perisa,Marija; Suton,Petar; Sarcevic,Bozena

doi:10.3892/ol.2016.5142

The prognostic significance of estrogen receptor β in head and neck squamous cell carcinoma

Authors:
- Kresimir Grsic
- Iva Ledinsky Opacic
- Sanda Sitic
- Marija Milkovic Perisa
- Petar Suton
- Bozena Sarcevic
View Affiliations

Affiliations: Division of Head and Neck Surgery, Department of Surgical Oncology, University Hospital for Tumors, Clinical Hospital Center Sisters of Charity, 10000 Zagreb, Croatia, Department of Clinical Pathology, University Hospital for Tumors, Clinical Hospital Center Sisters of Charity, 10000 Zagreb, Croatia, Division of Radiation Oncology, Department of Radiotherapy and Medical Oncology, University Hospital for Tumors, Clinical Hospital Center Sisters of Charity, 10000 Zagreb, Croatia
Published online on: September 15, 2016 https://doi.org/10.3892/ol.2016.5142
Pages: 3861-3865
Copyright: © Grsic et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer in the world. Although multimodal and targeted therapy is now used in therapeutic procedures, the survival of patients with HNSCC has remained unchanged over the last 30 years. A number of studies have demonstrated that the increased expression of intranuclear ERβ in breast, lung and colon cancer is a favorable prognostic marker associated with higher survival rates. However, the clinical significance of sex hormone receptors in HNSCC remains unclear. The current study aimed to assess the expression of ERβ in HNSCC immunohistochemically and investigate any possible association between ERβ expression, and clinical and histopathological factors, disease recurrence and patient survival. The present study included 174 patients (165 males and 9 females) with a median age of 60.8 years (range, 39‑79) with HNSCC who were primary surgically treated between January 2000 and December 2006. Immunohistochemical reactions for ERβ demonstrated that 73 patients (42%) exhibited positive ERβ expression. Distribution of ERβ status among different head and neck subsites indicated that >40% of all negative cases were located in laryngeal primaries, while incidence of other sublocalization within positive cases was similar and comparable (P=0.04). Furthermore, a correlation was observed between ERβ immunopositivity and the survival of patients, with respect to the primary tumor site. Patients with ERβ positive oropharyngeal cancer had a survival rate of 35.3% at 5‑years compared with 25% for patients with negative expression. However, ERβ status was not significantly correlated with any other clinical or histopathological parameter. After an average follow‑up time of 38.5 months (range, 3‑60 months), 54 patients (31.1%) had succumbed to disease recurrence while 50 (28.7%) succumbed to other causes. In conclusion, ERβ positivity indicates improved survival of patients with oropharyngeal cancer. Further research is required in order to implement novel therapeutic strategies.

View Figures

View References

1	Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar : PubMed/NCBI
2	Takenaka Y, Yasui T, Enomoto K, Miyabe H, Morizane N, Ashida N, Shimizu K, Hirose M, Yamamoto Y and Uno A: Health insurance status and survival among patients with head and neck cancer in Japan. Int J Clin Oncol. 21:517–522. 2016. View Article : Google Scholar : PubMed/NCBI
3	Razzouk S: Translational genomics and head and neck cancer: Toward precision medicine. Clin Genet. 86:412–421. 2014. View Article : Google Scholar : PubMed/NCBI
4	Machiels JP, Lambrecht M, Hanin FX, Duprez T, Gregoire V, Schmitz S and Hamoir M: Advances in the management of squamous cell carcinoma of the head and neck. F1000Prime Rep. 6:442014. View Article : Google Scholar : PubMed/NCBI
5	Sanderson RJ and Ironside JA: Squamous cell carcinomas of the head and neck. BMJ. 325:822–827. 2002. View Article : Google Scholar : PubMed/NCBI
6	Merino OR, Lindberg RD and Fletcher GH: An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 40:145–151. 1977. View Article : Google Scholar : PubMed/NCBI
7	Grégoire V, Lefebvre JL, Licitra L and Felip E: EHNS- ESMO-ESTRO Guidelines Working Group: Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 21(Suppl 5): v184–v186. 2010. View Article : Google Scholar : PubMed/NCBI
8	Schweitzer A, Knauer SK and Stauber RH: Nuclear receptors in head and neck cancer: Current knowledge and perspectives. Int J Cancer. 126:801–809. 2010.PubMed/NCBI
9	Wu CT, Chang YL, Shih JY and Lee YC: The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg. 130:979–986. 2005. View Article : Google Scholar : PubMed/NCBI
10	Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, Ono I, Minamiya Y and Ogawa J: Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res. 11:5084–5089. 2005. View Article : Google Scholar : PubMed/NCBI
11	Cheng J, Lee EJ, Madison LD and Lazennec G: Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett. 566:169–172. 2004. View Article : Google Scholar : PubMed/NCBI
12	Reese JM, Suman VJ, Subramaniam M, Wu X, Negron V, Gingery A, Pitel KS, Shah SS, Cunliffe HE, McCullough AE, et al: ERβ1: Characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer. BMC Cancer. 14:7492014. View Article : Google Scholar : PubMed/NCBI
13	Jassam N, Bell SM, Speirs V and Quirke P: Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep. 14:17–21. 2005.PubMed/NCBI
14	Lukits J, Remenár E, Rásó E, Ladányi A, Kásler M and Tímár J: Molecular identification, expression and prognostic role of estrogen-and progesterone receptors in head and neck cancer. Int J Oncol. 30:155–60. 2007.PubMed/NCBI
15	Ferlay J, Autier P, Boniol M, Heanue M, Colombet M and Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 18:581–592. 2007. View Article : Google Scholar : PubMed/NCBI
16	Budai B, Remenár E, Orosz Z, Számel I, Kralovánszky J and Kásler M: Steroid hormone receptors in squamous cell carcinoma of the head and neck. Orv Hetil. 138:723–727. 1997.(In Hungarian). PubMed/NCBI
17	Virolainen E, Tuohimaa P, Aitasalo K, Kyttä J and Vanharanta- Hiltunen R: Steroid hormone receptors in laryngeal carcinoma. Otolaryngol Head Neck Surg. 94:512–517. 1986. View Article : Google Scholar : PubMed/NCBI
18	Oğretmenoğlu O and Ayas K: Laryngeal carcinoma and estrogen receptor analysis in patients after long-term follow-up. Eur Arch Otorhinolaryngol. 255:457–461. 1998. View Article : Google Scholar : PubMed/NCBI
19	Goulioumis AK, Fuxe J, Varakis J, Repanti M, Goumas P and Papadaki H: Estrogen receptor-beta expression in human laryngeal carcinoma: Correlation with the expression of epithelial-mesenchymal transition specific biomarkers. Oncol Rep. 22:1063–1068. 2009.PubMed/NCBI
20	Egloff AM, Rothstein ME, Seethala R, Siegfried JM, Grandis JR and Stabile LP: Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma. Clin Cancer Res. 15:6529–6540. 2009. View Article : Google Scholar : PubMed/NCBI
21	Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th. Springer; New York: pp. 29–35. 2010
22	Niu XL, Wang Y, Yao Z, Duan H, Li Z, Liu W, Zhang H and Deng WM: Autocrine interferon-γ may affect malignant behavior and sensitivity to tamoxifen of MCF-7 via estrogen receptor β subtype. Oncol Rep. 34:3120–3130. 2015.PubMed/NCBI
23	Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G and Lefebvre JL: Cancer of the larynx. Crit Rev Oncol Hematol. 47:65–80. 2003. View Article : Google Scholar : PubMed/NCBI
24	Bianchini C, Pastore A, Pelucchi S, Torreggiani E, Lambertini E, Marchesi E, Magri E, Frasson C, Querzoli P and Piva R: Sex hormone receptor levels in laryngeal carcinoma: A comparison between protein and RNA evaluations. Eur Arch Otorhinolaryngol. 265:1089–1094. 2008. View Article : Google Scholar : PubMed/NCBI
25	Hagedorn HG and Nerlich AG: Analysis of sex-hormone-receptor expression in laryngeal carcinoma. Eur Arch Otorhinolaryngol. 259:205–210. 2002. View Article : Google Scholar : PubMed/NCBI
26	Schuller DE, Abou-Issa H and Parrish R: Estrogen and progesterone receptors in head and neck cancer. Arch Otolaryngol. 110:725–727. 1984. View Article : Google Scholar : PubMed/NCBI
27	Ferguson BJ, Hudson WR and McCarty KS Jr: Sex steroid receptor distribution in the human larynx and laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 113:1311–1315. 1987. View Article : Google Scholar : PubMed/NCBI
28	Nozoe T, Oyama T, Takenoyama M, Hanagiri T, Sugio K and Yasumoto K: Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus. Clin Cancer Res. 13:4046–4050. 2007. View Article : Google Scholar : PubMed/NCBI
29	Wang QM, Qi YJ, Jiang Q, Ma YF and Wang LD: Relevance of serum estradiol and estrogen receptor beta expression from a high-incidence area for esophageal squamous cell carcinoma in China. Med Oncol. 28:188–193. 2011. View Article : Google Scholar : PubMed/NCBI
30	Dong J, Jiang SW, Niu Y, Chen L, Liu S, Ma T, Chen X, Xu L, Su Z and Chen H: Expression of estrogen receptor α and β in esophageal squamous cell carcinoma. Oncol Rep. 30:2771–2776. 2013.PubMed/NCBI
31	Ishida H, Wada K, Masuda T, Okura M, Kohama K, Sano Y, Nakajima A, Kogo M and Kamisaki Y: Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma. Cancer Sci. 98:636–643. 2007. View Article : Google Scholar : PubMed/NCBI